The U.S. life sciences industry is entering one of its most exciting - yet challenging - periods in decad es. With capital Markets favouring disciplined innovators and regulators f ocusing on real clinical improvements, these pressures will define the nex t generation of global healthcare leaders.
Using the real-world experience of Medcura, a Ma ryland-based biosurgery company developing new technology for spinal surge ry, Jim Buck will share what it takes today to develop, fund, and m ove forward groundbreaking medical devices in the U.S.
Jim will explore the cooperation between American innovators and European scientifi c, regulatory, and investment communities. As medtech platforms expand glo bally earlier in their development, combining the U.S. venture capital rig or, Europe&rsquo\;s technical expertise and its increasing investment appe tite is becoming a major competitive advantage.
Attendees will gain a candid view o f how companies like Medcura navigate these Europe-Atlantic dynamics and w hy the next wave of value creation will belong to those who understand bot h worlds.
\;
The names of at tendees at our events may also be shared with other attendees at the same event\; if you do not want your name included on such list of attendees, p lease also let us know in writing.
\;